nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone decanoate—Haemoglobin increased—Vandetanib—thyroid cancer	0.196	0.259	CcSEcCtD
Nandrolone decanoate—Furuncle—Vandetanib—thyroid cancer	0.05	0.0663	CcSEcCtD
Nandrolone decanoate—Hoarseness—Sorafenib—thyroid cancer	0.0376	0.0499	CcSEcCtD
Nandrolone decanoate—Oligospermia—Epirubicin—thyroid cancer	0.0292	0.0387	CcSEcCtD
Nandrolone decanoate—Acne—Vandetanib—thyroid cancer	0.0292	0.0386	CcSEcCtD
Nandrolone decanoate—Oligospermia—Doxorubicin—thyroid cancer	0.027	0.0358	CcSEcCtD
Nandrolone decanoate—Azoospermia—Epirubicin—thyroid cancer	0.0227	0.0301	CcSEcCtD
Nandrolone decanoate—Azoospermia—Doxorubicin—thyroid cancer	0.021	0.0279	CcSEcCtD
Nandrolone decanoate—Dysphonia—Sorafenib—thyroid cancer	0.0201	0.0267	CcSEcCtD
Nandrolone decanoate—AR—Coregulation of Androgen receptor activity—NCOA4—thyroid cancer	0.0171	0.0758	CbGpPWpGaD
Nandrolone decanoate—Gynaecomastia—Sorafenib—thyroid cancer	0.0148	0.0196	CcSEcCtD
Nandrolone decanoate—AR—Regulation of Androgen receptor activity—TRIM24—thyroid cancer	0.0145	0.0643	CbGpPWpGaD
Nandrolone decanoate—Furunculosis—Epirubicin—thyroid cancer	0.0144	0.0191	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Sorafenib—thyroid cancer	0.0137	0.0182	CcSEcCtD
Nandrolone decanoate—Furunculosis—Doxorubicin—thyroid cancer	0.0133	0.0176	CcSEcCtD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—NCOA4—thyroid cancer	0.0127	0.0561	CbGpPWpGaD
Nandrolone decanoate—Furuncle—Epirubicin—thyroid cancer	0.0125	0.0165	CcSEcCtD
Nandrolone decanoate—AR—Nuclear Receptors—THRB—thyroid cancer	0.0122	0.0541	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—CITED1—thyroid cancer	0.0122	0.0539	CbGpPWpGaD
Nandrolone decanoate—Furuncle—Doxorubicin—thyroid cancer	0.0115	0.0153	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Vandetanib—thyroid cancer	0.0111	0.0147	CcSEcCtD
Nandrolone decanoate—Local reaction—Epirubicin—thyroid cancer	0.011	0.0146	CcSEcCtD
Nandrolone decanoate—Local reaction—Doxorubicin—thyroid cancer	0.0102	0.0135	CcSEcCtD
Nandrolone decanoate—AR—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.00964	0.0427	CbGpPWpGaD
Nandrolone decanoate—Erectile dysfunction—Sorafenib—thyroid cancer	0.00956	0.0127	CcSEcCtD
Nandrolone decanoate—Hypertension—Vandetanib—thyroid cancer	0.00926	0.0123	CcSEcCtD
Nandrolone decanoate—Jaundice—Sorafenib—thyroid cancer	0.00902	0.012	CcSEcCtD
Nandrolone decanoate—Seborrhoeic dermatitis—Epirubicin—thyroid cancer	0.00897	0.0119	CcSEcCtD
Nandrolone decanoate—Oedema—Vandetanib—thyroid cancer	0.00875	0.0116	CcSEcCtD
Nandrolone decanoate—Hyperlipidaemia—Epirubicin—thyroid cancer	0.00849	0.0112	CcSEcCtD
Nandrolone decanoate—Seborrhoeic dermatitis—Doxorubicin—thyroid cancer	0.0083	0.011	CcSEcCtD
Nandrolone decanoate—Hyperlipidaemia—Doxorubicin—thyroid cancer	0.00785	0.0104	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Sorafenib—thyroid cancer	0.00749	0.00993	CcSEcCtD
Nandrolone decanoate—Dysphonia—Epirubicin—thyroid cancer	0.00743	0.00985	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Epirubicin—thyroid cancer	0.00696	0.00923	CcSEcCtD
Nandrolone decanoate—Dysphonia—Doxorubicin—thyroid cancer	0.00688	0.00912	CcSEcCtD
Nandrolone decanoate—CYP19A1—Endogenous sterols—RXRA—thyroid cancer	0.00667	0.0295	CbGpPWpGaD
Nandrolone decanoate—Amenorrhoea—Doxorubicin—thyroid cancer	0.00644	0.00854	CcSEcCtD
Nandrolone decanoate—Hypertension—Sorafenib—thyroid cancer	0.00625	0.00828	CcSEcCtD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TCF7L1—thyroid cancer	0.00621	0.0275	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Vandetanib—thyroid cancer	0.00619	0.00821	CcSEcCtD
Nandrolone decanoate—Fluid retention—Epirubicin—thyroid cancer	0.00581	0.0077	CcSEcCtD
Nandrolone decanoate—Rash—Vandetanib—thyroid cancer	0.00552	0.00731	CcSEcCtD
Nandrolone decanoate—Dermatitis—Vandetanib—thyroid cancer	0.00551	0.00731	CcSEcCtD
Nandrolone decanoate—Fluid retention—Doxorubicin—thyroid cancer	0.00537	0.00712	CcSEcCtD
Nandrolone decanoate—Nausea—Vandetanib—thyroid cancer	0.0052	0.00689	CcSEcCtD
Nandrolone decanoate—AR—Nuclear Receptors—RXRA—thyroid cancer	0.00519	0.023	CbGpPWpGaD
Nandrolone decanoate—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00508	0.00673	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.0047	0.00623	CcSEcCtD
Nandrolone decanoate—Urticaria—Sorafenib—thyroid cancer	0.00469	0.00622	CcSEcCtD
Nandrolone decanoate—CYP19A1—Metapathway biotransformation—CHST14—thyroid cancer	0.00452	0.02	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—RET—thyroid cancer	0.00424	0.0188	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Sorafenib—thyroid cancer	0.00418	0.00554	CcSEcCtD
Nandrolone decanoate—MAOB—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.0041	0.0182	CbGpPWpGaD
Nandrolone decanoate—AR—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.0041	0.0182	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of Androgen receptor activity—RXRA—thyroid cancer	0.00397	0.0176	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.00394	0.0175	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—RET—thyroid cancer	0.00374	0.0166	CbGpPWpGaD
Nandrolone decanoate—Rash—Sorafenib—thyroid cancer	0.00372	0.00493	CcSEcCtD
Nandrolone decanoate—Dermatitis—Sorafenib—thyroid cancer	0.00372	0.00493	CcSEcCtD
Nandrolone decanoate—Nausea—Sorafenib—thyroid cancer	0.00351	0.00465	CcSEcCtD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.00348	0.0154	CbGpPWpGaD
Nandrolone decanoate—Jaundice—Epirubicin—thyroid cancer	0.00333	0.00442	CcSEcCtD
Nandrolone decanoate—AR—Nuclear Receptors—PPARG—thyroid cancer	0.00327	0.0145	CbGpPWpGaD
Nandrolone decanoate—AR—Notch-mediated HES/HEY network—HIF1A—thyroid cancer	0.00325	0.0144	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.0031	0.0137	CbGpPWpGaD
Nandrolone decanoate—Jaundice—Doxorubicin—thyroid cancer	0.00309	0.00409	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Epirubicin—thyroid cancer	0.00277	0.00367	CcSEcCtD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—TPR—thyroid cancer	0.00273	0.0121	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.00262	0.0116	CbGpPWpGaD
Nandrolone decanoate—AR—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.00259	0.0115	CbGpPWpGaD
Nandrolone decanoate—MAOA—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.00257	0.0114	CbGpPWpGaD
Nandrolone decanoate—Mediastinal disorder—Doxorubicin—thyroid cancer	0.00256	0.00339	CcSEcCtD
Nandrolone decanoate—CYP19A1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.00251	0.0111	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—TPR—thyroid cancer	0.00235	0.0104	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.00231	0.0102	CbGpPWpGaD
Nandrolone decanoate—Hypertension—Epirubicin—thyroid cancer	0.00231	0.00306	CcSEcCtD
Nandrolone decanoate—AR—Generic Transcription Pathway—TRIM33—thyroid cancer	0.0023	0.0102	CbGpPWpGaD
Nandrolone decanoate—MAOA—neck—thyroid cancer	0.00229	0.115	CbGeAlD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—thyroid cancer	0.00222	0.00984	CbGpPWpGaD
Nandrolone decanoate—Oedema—Epirubicin—thyroid cancer	0.00218	0.00289	CcSEcCtD
Nandrolone decanoate—MAOB—Biological oxidations—RXRA—thyroid cancer	0.00218	0.00965	CbGpPWpGaD
Nandrolone decanoate—Hypertension—Doxorubicin—thyroid cancer	0.00214	0.00283	CcSEcCtD
Nandrolone decanoate—MAOB—saliva-secreting gland—thyroid cancer	0.00209	0.105	CbGeAlD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—SST—thyroid cancer	0.00207	0.00918	CbGpPWpGaD
Nandrolone decanoate—Oedema—Doxorubicin—thyroid cancer	0.00202	0.00268	CcSEcCtD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—SST—thyroid cancer	0.00183	0.0081	CbGpPWpGaD
Nandrolone decanoate—MAOA—saliva-secreting gland—thyroid cancer	0.00179	0.0898	CbGeAlD
Nandrolone decanoate—Urticaria—Epirubicin—thyroid cancer	0.00173	0.0023	CcSEcCtD
Nandrolone decanoate—AR—Nongenotropic Androgen signaling—HRAS—thyroid cancer	0.00173	0.00765	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—THRB—thyroid cancer	0.00167	0.00738	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Doxorubicin—thyroid cancer	0.0016	0.00213	CcSEcCtD
Nandrolone decanoate—MAOB—Metabolism—MINPP1—thyroid cancer	0.0016	0.00709	CbGpPWpGaD
Nandrolone decanoate—AR—Coregulation of Androgen receptor activity—CCND1—thyroid cancer	0.00159	0.00706	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Epirubicin—thyroid cancer	0.00154	0.00205	CcSEcCtD
Nandrolone decanoate—AR—Nongenotropic Androgen signaling—AKT1—thyroid cancer	0.00152	0.00675	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—FSH signaling pathway—AKT1—thyroid cancer	0.00146	0.00649	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Doxorubicin—thyroid cancer	0.00143	0.00189	CcSEcCtD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.00142	0.00631	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.00142	0.00628	CbGpPWpGaD
Nandrolone decanoate—MAOA—trachea—thyroid cancer	0.00138	0.0692	CbGeAlD
Nandrolone decanoate—Rash—Epirubicin—thyroid cancer	0.00138	0.00182	CcSEcCtD
Nandrolone decanoate—Dermatitis—Epirubicin—thyroid cancer	0.00137	0.00182	CcSEcCtD
Nandrolone decanoate—MAOA—Biological oxidations—RXRA—thyroid cancer	0.00137	0.00606	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—NDUFA13—thyroid cancer	0.00136	0.00603	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—thyroid gland—thyroid cancer	0.00136	0.0682	CbGeAlD
Nandrolone decanoate—CYP19A1—Biological oxidations—RXRA—thyroid cancer	0.00133	0.00591	CbGpPWpGaD
Nandrolone decanoate—Nausea—Epirubicin—thyroid cancer	0.0013	0.00172	CcSEcCtD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—thyroid cancer	0.00128	0.00568	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CHST14—thyroid cancer	0.00128	0.00567	CbGpPWpGaD
Nandrolone decanoate—MAOB—thyroid gland—thyroid cancer	0.00128	0.0642	CbGeAlD
Nandrolone decanoate—Rash—Doxorubicin—thyroid cancer	0.00127	0.00169	CcSEcCtD
Nandrolone decanoate—Dermatitis—Doxorubicin—thyroid cancer	0.00127	0.00169	CcSEcCtD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.00124	0.00551	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—head—thyroid cancer	0.0012	0.0605	CbGeAlD
Nandrolone decanoate—AR—thyroid gland—thyroid cancer	0.0012	0.0604	CbGeAlD
Nandrolone decanoate—Nausea—Doxorubicin—thyroid cancer	0.0012	0.00159	CcSEcCtD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—CCND1—thyroid cancer	0.00118	0.00522	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—PTEN—thyroid cancer	0.00114	0.00504	CbGpPWpGaD
Nandrolone decanoate—MAOB—head—thyroid cancer	0.00113	0.057	CbGeAlD
Nandrolone decanoate—AR—Gene Expression—TRIM33—thyroid cancer	0.00111	0.00492	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.0011	0.00486	CbGpPWpGaD
Nandrolone decanoate—MAOA—thyroid gland—thyroid cancer	0.00109	0.0548	CbGeAlD
Nandrolone decanoate—AR—head—thyroid cancer	0.00107	0.0536	CbGeAlD
Nandrolone decanoate—AR—Generic Transcription Pathway—MEN1—thyroid cancer	0.00106	0.00469	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—BRAF—thyroid cancer	0.00106	0.00469	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—HPGD—thyroid cancer	0.00103	0.00457	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—MINPP1—thyroid cancer	0.001	0.00445	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—MINPP1—thyroid cancer	0.000979	0.00434	CbGpPWpGaD
Nandrolone decanoate—MAOA—head—thyroid cancer	0.000967	0.0486	CbGeAlD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—BRAF—thyroid cancer	0.00091	0.00403	CbGpPWpGaD
Nandrolone decanoate—AR—Coregulation of Androgen receptor activity—AKT1—thyroid cancer	0.000886	0.00393	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NDUFA13—thyroid cancer	0.000854	0.00378	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—lymph node—thyroid cancer	0.000843	0.0424	CbGeAlD
Nandrolone decanoate—CYP19A1—Metabolism—NDUFA13—thyroid cancer	0.000833	0.00369	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CHST14—thyroid cancer	0.000803	0.00356	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—THRB—thyroid cancer	0.000802	0.00355	CbGpPWpGaD
Nandrolone decanoate—MAOB—lymph node—thyroid cancer	0.000794	0.0399	CbGeAlD
Nandrolone decanoate—CYP19A1—Metabolism—CHST14—thyroid cancer	0.000783	0.00347	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—CCND1—thyroid cancer	0.000772	0.00342	CbGpPWpGaD
Nandrolone decanoate—AR—lymph node—thyroid cancer	0.000747	0.0375	CbGeAlD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000745	0.0033	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	0.000745	0.0033	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—RXRA—thyroid cancer	0.000708	0.00314	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000708	0.00314	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—thyroid cancer	0.000706	0.00313	CbGpPWpGaD
Nandrolone decanoate—MAOA—lymph node—thyroid cancer	0.000677	0.034	CbGeAlD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—thyroid cancer	0.000664	0.00294	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—AKT1—thyroid cancer	0.000655	0.0029	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—HPGD—thyroid cancer	0.000647	0.00287	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	0.000641	0.00284	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000639	0.00283	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—HPGD—thyroid cancer	0.000631	0.0028	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.000617	0.00274	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—TPR—thyroid cancer	0.000592	0.00262	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PRKAR1A—thyroid cancer	0.000583	0.00258	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	0.000572	0.00253	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—BRAF—thyroid cancer	0.000571	0.00253	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—TPR—thyroid cancer	0.000542	0.0024	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000512	0.00227	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—MEN1—thyroid cancer	0.000509	0.00226	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—TP53—thyroid cancer	0.000508	0.00225	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	0.000492	0.00218	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000474	0.0021	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—PPARG—thyroid cancer	0.000447	0.00198	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—SLC5A5—thyroid cancer	0.000443	0.00196	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—TP53—thyroid cancer	0.000437	0.00194	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	0.000429	0.0019	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.000421	0.00187	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—RXRA—thyroid cancer	0.000373	0.00165	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—TPR—thyroid cancer	0.000372	0.00165	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	0.000369	0.00164	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PRKAR1A—thyroid cancer	0.000366	0.00162	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—TPR—thyroid cancer	0.000362	0.00161	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PRKAR1A—thyroid cancer	0.000357	0.00158	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.000356	0.00158	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000343	0.00152	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—RXRA—thyroid cancer	0.000341	0.00151	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000323	0.00143	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—SLC5A5—thyroid cancer	0.000278	0.00123	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—SLC5A5—thyroid cancer	0.000271	0.0012	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—HRAS—thyroid cancer	0.000262	0.00116	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000254	0.00113	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PPARG—thyroid cancer	0.000235	0.00104	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—RXRA—thyroid cancer	0.000234	0.00104	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—RXRA—thyroid cancer	0.000228	0.00101	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.000222	0.000983	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—PPARG—thyroid cancer	0.000215	0.000953	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PTGS2—thyroid cancer	0.000185	0.00082	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PTEN—thyroid cancer	0.000161	0.000715	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PPARG—thyroid cancer	0.000148	0.000654	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PPARG—thyroid cancer	0.000144	0.000638	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PTGS2—thyroid cancer	0.000116	0.000515	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PTGS2—thyroid cancer	0.000113	0.000502	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PTEN—thyroid cancer	0.000101	0.000449	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PTEN—thyroid cancer	9.88e-05	0.000438	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—AKT1—thyroid cancer	9.3e-05	0.000412	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—AKT1—thyroid cancer	8.51e-05	0.000377	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—AKT1—thyroid cancer	5.84e-05	0.000259	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—AKT1—thyroid cancer	5.69e-05	0.000252	CbGpPWpGaD
